Medicines Board withdraws diabetes treatment

A drug used to treat diabetes has been withdrawn by the Irish Medicines Board after a warning from the EU.

Medicines Board withdraws diabetes treatment
Thu, 23 Sep, 2010 - 19:07

A drug used to treat diabetes has been withdrawn by the Irish Medicines Board after a warning from the EU.

There are fears Rosiglitazone, also known by the brand names Avandia, Avandamet and Avaglim, may impact on cardiovascular health.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

Benefit image

Introductory offer. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €10/month. Ts&Cs apply.

WhatsApp logo

Irish Examiner’s WhatsApp channel

More in this section

Donabate missing boy Gardaí ask drone operators to keep away from search for missing boy
Fine Gael party think-in Deepfake video of Heather Humphreys reported to Meta
RTÉ says Ireland will withdraw from Eurovision if Israel is allowed to compete RTÉ says Ireland will withdraw from Eurovision if Israel is allowed to compete
CourtsHeathrowOrganisation: Medicines BoardOrganisation: Irish Medicines BoardOrganisation: EUOrganisation: RosiglitazoneOrganisation: AvandiaOrganisation: AvandametOrganisation: AvaglimOrganisation: IMB
<p>Sentencing was adjourned until October 8 for the judge to consider the ramifications of applying the Probation Act. Judge Hughes also asked prosecuting counsel John Griffin to provide clarity on that issue and how it would impact Garda vetting. File picture: Derick Hudson</p>

Garda Superintendent cleared of assault, but charged with public order offence 

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited